Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors

Clinical Cancer Research

Volumn 9, Issue 7, 2003, Pages 2406-2415

  Pusztai, Lajos ^a   Ayers, Mark ^b   Stec, James ^b   Clark, Edward ^b   Hess, Kenneth ^a   Stivers, David ^a   Damokosh, Andrew ^b   Sneige, Nour ^a   Buchholz, Thomas A ^a   Esteva, Francisco J ^a   Arun, Banu ^a   Cristofanilli, Massimo ^a   Booser, Daniel ^a   Rosales, Marguerite ^a   Valero, Vicente ^a   Adams, Constantine ^a   Hortobagyi, Gabriel N ^a   Fraser Symmans, W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Millennium Predictive Medicine Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; CYTIDINE TRIPHOSPHATE; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; RNA;

ADULT; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CANCER CELL; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; CELL COMPOSITION; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA HYBRIDIZATION; DNA MICROARRAY; DNA PROBE; FEMALE; FLUORESCENCE; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; ONCOGENE NEU; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RELIABILITY; SEQUENCE TAGGED SITE; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; VALIDATION PROCESS;

ADULT; AGED; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; CLUSTER ANALYSIS; DNA, COMPLEMENTARY; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RNA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 12444326150     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. King, H. C., and Sinha, A. A. Gene expression profile analysis by DNA microarrays. JAMA, 286: 2280-2288, 2001.
2. Khan, J., Wei, J. S., Ringner, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., and Peterson, C. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med., 7: 673-660, 2001.
3. Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., and Kallioniemi, O. P. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med., 344: 539-548, 2001.
4. Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C., Lashkari, D., Shalon, D., Brown, P. O., and Botstein, D. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA, 96: 9212-9217, 1999.
5. Gruvberger, S., Ringner, M., Chen, Y., Panavally, S., Saal, L. H., Borg, A., Ferno, M., Peterson, C., and Meltzer, P. S. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res., 61: 5979-5984, 2001.
6. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Lonning, P. E., and Borresen-Dale, A. L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA, 98: 10869-10874, 2001.
7. West, M., Blanchette, C., Dressman, H., Huang, E., Ishida, S., Spang, R., Zuzan, H., Olson, A., Jr., Marks, J. R., and Nevins, J. R. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. USA, 98: 11462-11467, 2001.
8. van't Veer, L. J., Dai, H., Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., Kooy, K., Marton, M., Witteveen, A. T., Schreiber, G. J., Kerkhoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond.), 415: 530-535, 2002.
9. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., and Johnsen, H. Molecular portraits of human breast tumors. Nature (Lond.), 406: 747-752, 2000.
10. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., and Powell, J. I. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (Lond.), 403: 503-511, 2000.
11. Anbazhagan, R., Tihan, T., Bornman, D. M., Johnston, J. C., Saltz, J. H., Weigering, A., Piantadosi, S., and Gabrielson, E. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res., 59: 5119-5122, 1999.
12. Su, A. I., Welsh, J. B., Sapinoso, L. M., Kern, S. G., Dimitrov, P., Lapp, H., Schultz, P. G., Powell, S. M., Moskaluk, C. A., and Frierson, H. F., Jr. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res., 61: 7388-7393, 2001.
13. Takahashi, M., Rhodes, D. R., Furge, K. A., Kanayama, H., Kagawa, S., Haab, B. B., and The, B. T. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc. Natl. Acad. Sci. USA, 98: 9754-9759, 2001.
14. Deininger, P. L., Batzer, M. A. Alu repeats and human disease. Mol. Genet. Metab., 67: 183-193, 1999.
15. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95: 14863-14868, 1998.
16. Dunmire, V., Wu, C., Symmans, W. F., and Zhang, W. Increased yield of total RNA from fine-needle aspirates for use in expression microarray analysis. Biotechniques, 33: 890-896, 2002.
17. Ellis, M., Davis, N., Coop, A., Liu, M., Schumaker, L., Lee, R. Y., Srikanchana, R., Russel, C., Singh, B., Miller, W. R., et al. Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses. Clin. Cancer Res., 8: 1155-1166, 2002.
18. Assersohn, L., Gangi, L., Zhao, Y., Dowsett, M., Simon, R., Powles, T. J., and Liu, E. T. The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses. Clin. Cancer Res., 8: 794-801, 2002.
19. Anderson, J. M., Clarke, E., Howell, R., et al. Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes. Breast Cancer Res. Treat., 41: 31-41, 1996.
20. Sarkar, F. H., Visscher, D. W., and Crissman, J. D. Quantitative analysis of Her-2/neu (ERBB2) gene expression using reverse transcriptase polymerase chain reaction. Diagn. Mol. Pathol., 2: 210-218, 1993.
21. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., and Ullrich, A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Wash. DC), 244: 707-712, 1989.
22. Sorlie T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., and Jeffrey, S. S. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA, 98: 10869-10874, 2001.
23. Charpentier, A. H., Bednarek, A. K., Daniel, R. L., Hawkins, K. A., Laflin, K. J., Gaddis, S., MacLeod, M. C., and Aldaz, C. M. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res., 60: 5977-5983, 2000.
24. Clark, M. Prognostic and predictive factors. In: J. R. Harris, M. Lippman, M. E. Morrow, and M. S. Hellman (eds.), Diseases of the Breast, pp. 461-485. Philadelphia: Lippincott-Raven, 1996.
25. Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., and Atkins, J. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. (Bethesda), 90: 1371-1388, 1998.
26. Li, Z., Zhang, Y., Li, D., and Feng, Y. Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J. Neurosci., 20: 4944-4953, 2000.
27. Wisniewski, J. R., and Schwanbeck, R. High mobility group I/Y: multifunctional chromosomal proteins causally involved in tumor progression and malignant transformation. Intl. J. Mol. Med., 6: 409-419, 2000.
28. Richardson, R. T., Batova, I. N., Widgren, E. E., Zheng, L. X., Whitfield, M., Marzluff, W. F., and O'Rand, M. G. Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. J. Biol. Chem., 275: 30378-30386, 2000.
29. Celano, P., Berchtold, C. M., Giardiello, F. M., and Casero, R. A., Jr. Modulation of growth gene expression by selective alteration of polyamines in human colon carcinoma cells. Biochem. Biophys. Res. Comm., 165: 384-390, 1989.
30. Gallouzi, I. E., and Steitz, J. A. Delineation of mRNA export pathways by the use of cell-permeable peptides. Science (Wash. DC), 294: 1895-1901, 2001.
31. Davido, T., and Getzenberg, R. H. Nuclear matrix proteins as cancer markers. J. Cell. Biochem. Suppl., 35: 136-141, 2000.
32. Symmans, W. F., Pusztai, L., Ayers, M., Clark, E., Stec, J., Buchholz, T. A., Sneige, N., and Hortobagyi, G. N. RNA yield from needle biopsies for cDNA microarray analysis of breast cancer prior to neoadjuvant chemotherapy. Breast Cancer Res. Treat., 69: 301, 2001.
33. Ayers, M., Symmans, W. F., Stec, J., Metivier, J., Damokosh, A., Clark, E., Sneige, N., Carter, C., Whitman, G., Hortobagyi, G. N., and Pusztai, L. Gene expression profiling of fine needle aspirations of breast cancer identifies genes associated with complete pathologic response to neoadjuvant Taxol/FAC chemotherapy. Breast Cancer Res. Treat., 76: S64, 2002.